Efficacy and Safety of Bisphosphonates for Postmenopausal Women: A Systematic Review and Network Meta-analysis
Fragility fractures caused by loss of bone mass due to postmenopausal osteoporosis represent a growing morbidity worldwide. Bisphosphonates are first-line medications for fracture treatment and prevention. In the first phase, we updated a Cochrane systematic review of randomized controlled trials on...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2019
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/38849 http://dx.doi.org/10.20381/ruor-23101 |